Nature Medicine retracts study claiming morning immunotherapy improves lung cancer outcomes

Nature Medicine has retracted a high-profile clinical trial paper that claimed lung cancer patients receiving immunotherapy in the morning had significantly better outcomes than those treated after 3 p.m. The retraction follows an investigation that found problems with the study,